e-learning
resources
Milan 2017
Sunday, 10.09.2017
Systemic and airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Beclin1 circulating levels and accelerated ageing markers in COPD
F. Schlemmer (Créteil Cedex, France)
Source:
International Congress 2017 – Systemic and airway biomarkers
Session:
Systemic and airway biomarkers
Session type:
Thematic Poster
Number:
1018
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Schlemmer (Créteil Cedex, France). Beclin1 circulating levels and accelerated ageing markers in COPD. 1018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Endoscopy
Related content which might interest you:
Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes?
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Leptin levels are associated with reduced lung function in men with COPD
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
DNA-estimated ageing markers are associated with COPD
Source: International Congress 2018 – Role of omics in population studies
Year: 2018
MMP-2 expression in lung periphery is related to COPD progression
Source: Eur Respir J 2006; 28: Suppl. 50, 550s
Year: 2006
Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Elevated serum levels of oxidative stress biomarkers in patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Characterisation of asthma subgroups associated with circulating YKL-40 levels
Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017
Year: 2017
Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Inflammation-sensitive plasma proteins are associated with increased incidence of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 629s
Year: 2007
Carbocisteine in vivo reduces circulating miR-21 and IL-8 in exacerbated COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients
Source: Eur Respir J 2015; 45: 1482-1485
Year: 2015
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept